iRobot Corporation sued for deceptive business practices

A class action lawsuit has been initiated by Rosen Law Firm against iRobot Corporation, alleging that the company provided false information to its investors. The legal action claims that iRobot misrepresented the advantages of its restructuring plan and made inaccurate statements about its ability to remain operational. Those who incurred financial losses may be qualified to join the lawsuit and potentially receive compensation.

The lawsuit, recently filed by Rosen Law Firm, specifically targets iRobot Corporation (NASDAQ: IRBT) for allegedly deceiving shareholders with regards to its business practices. According to the lawsuit, which covers investors who bought iRobot securities between January 29, 2024, and March 11, 2025, iRobot exaggerated the benefits of its restructuring plan and falsely assured stakeholders about its sustainability as a business.

According to the complaint lodged by Rosen Law Firm, iRobot failed to disclose pertinent information regarding its business, operations, and future prospects. The alleged misrepresentation included overstating the impact of the restructuring plan following the termination of the Amazon Acquisition and suggesting that iRobot might struggle to operate profitably as an independent entity. Ultimately, there were doubts about iRobot’s financial stability and potential to stay afloat.

If shareholders suffered monetary losses due to the wrongful information provided by iRobot, they may be eligible to partake in the class action lawsuit. The deadline to request to be the lead plaintiff in the case is September 5, 2025.

For additional information, affected shareholders can reach out to Rosen Law Firm by filling out a form, contacting attorney Phillip Kim via email, or calling 866-767-3653. Rosen Law Firm is recognized for its expertise in litigating for shareholder rights and has successfully secured over $1 billion for shareholders throughout its existence.

Rosen Law Firm is dedicated to assisting shareholders in recovering their losses and ensuring accountability from company executives involved in malpractice. The firm operates on a contingency fee basis, meaning shareholders are not required to pay any fees or expenses upfront.